A FINEH Protein Trial - Part 1

Acute Food INtake Effect of Hemp Protein (A FINEH Protein) Trial - Part 1 - Acute Effects of Hemp Protein on Blood Glucose, Appetite, Blood Pressure and Food Intake.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02366598

Enrollment

Registered

2015-02-19

Start date

2015-05-31

Completion date

2017-09-30

Last updated

2023-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Prevention, Obesity Prevention

Brief summary

The objectives of this trial are to assess the health benefits of acute hemp protein consumption compared to soybean protein and a non-protein control on: 1) blood glucose, appetite and blood pressure for one hour following consumption, 2) food intake at an ad libitum meal one hour following consumption and 3) blood glucose, appetite and blood pressure following the ad libitum meal to determine the second meal effect of hemp protein.

Interventions

OTHERHemp shake

Hemp protein shake

OTHERSoybean shake

Soybean protein shake

OTHERControl

Non-protein shake

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* Normoglycemic (\<5.6 mmol/L) * Body mass index (BMI) of 18.5-29.9 kg/m2 Participants will be excluded if they regularly skip breakfast, smoke, or consuming medications that may influence study outcomes or have experienced any gastrointestinal related health conditions/surgeries over the past year.

Exclusion criteria

* Restrained eaters * Regularly skip breakfast * Smokers * Those who are active (organized activities or athletic training at a high intensity; ≥ 150 min per week of moderate to vigorous physical activity) * Those on medications that may influence study outcomes or have experienced any gastrointestinal related health conditions/surgeries over the past year.

Design outcomes

Primary

Measure	Time frame	Description
Blood pressure	0-200 min	Measured by automated bood pressure cuff
Blood glucose concentration	0-200 min	Measured in blood by glucometer
Appetite	0-200 min	Measured by VAS Questionnaire
Food intake	0-200 min	Ad-libitum meal

Secondary

Measure	Time frame	Description
Physical comfort	0 - 200 min	Measured by VAS questionnaire
Energy/fatigue	0 - 200 min	Measured by VAS questionnaire
Palatability of treatments and meal	5 -80 minutes	Measured by VAS questionnaire

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026